Volume 3, Issue 2 (Summer 2016)                   JECH 2016, 3(2): 16-22 | Back to browse issues page



DOI: 10.21859/jech-03023

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Massomi Z, Khani S, Gharosian M, Farhadian M, Shayan A. The Prevalence of Abnormal Pap Smears in females Referred to Health Centers Affiliated to Medical Sciences During the Years 2012 to 2016. JECH. 2016; 3 (2) :16-22
URL: http://jech.umsha.ac.ir/article-1-221-en.html

1- Assistant Professor, Department of Midwifery, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran.
2- BSc, Department of midwifery,school of Nursing and Midwifery,Students Research Center,Hamadan university of medical sciences,Hamadan,Iran.
3- BSc, Fatemieh Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.
4- Assistant Professor, Department of Biostatistics, School of Public Health, Modeling of No communicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
5- MSc, Department of Midwifery, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran , arezoo.shayan2012@yahoo.com
Abstract:   (2042 Views)

Background and Objectives: Cervical cancer is one of the most important female reproductive system diseases. The aim of this study was to estimate the prevalence of abnormal Pap smears of pregnant females in public health centers and hospitals of Hamadan.

Materials and Methods: In a retrospective study, 36046 Pap smears of females was extracted from the records referred to government health centers affiliated to Hamadan University of Medical Sciences and Fatemiyeh Hospital Hamadan, between 2012 and 2016. After checking the results of Pap smear, abnormal information (605 cases) were collected and investigated. Data were then analyzed using the SPSS21-software and descriptive statistics and one-way Analysis of Variance (ANOVA).

Results: The majority of females with abnormal Pap smear results (%30.4) were aged 45 to 36 years, and %48.6 of females with abnormal Pap smear had parity (1-3). From a total of 36046 cases, 605 cases of abnormal Pap smear were observed. The highest and lowest frequencies of abnormal Pap smear were related to ASCUS and LSIL, at a prevalence of %78 and %1, respectively. There was a positive relationship between abnormal Pap smear results and age (P = 0.037).

Conclusions: The prevalence of abnormal Pap smear in Hamadan was %1.67. Malignant cervical cancer and invasive cancer risk increased with age, hence, screening and Pap smear, especially from age 35 and above, is recommended.

Full-Text [PDF 152 kb]   (625 Downloads)    
Type of Study: Research Article | Subject: General
Received: 2016/06/12 | Accepted: 2016/09/20

References
1. Bahreini F, Kianpoor M, Allameh T, Allama T, Bahrain F, Kianpour M. [Abnormal Pap smear in health centers and private clinics in Isfahan, 1996-97]. J Isfahan Med Sch. 2004;21(71):28-31.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917. [DOI] [PubMed]
3. IMo H. Iran Cancer Report 2009. Tehran: Cancer Registration Office, 2012.
4. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-403. [DOI] [PubMed]
5. Berek J, Novak E. Berek and Novak’s Gynecology. Philadelphia: Lippincott Williams & Wilkins; 2012.
6. Radnia N, Garousian M, Khani S, Shayan A, Hamoon H, Karami M. Prevalence of abnormal pap smearin employed women. Int J Adv Biotechnol Res. 2016;7(2):823-8.
7. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2007;109(2 Pt 1):360-70. [PubMed]
8. Dobbs SP, Asmussen T, Nunns D, Hollingworth J, Brown LJ, Ireland D. Does histological incomplete excision of cervical intraepithelial neoplasia following large loop excision of transformation zone increase recurrence rates? A six year cytological follow up. BJOG. 2000; 107(10): 1298-301. [PubMed]
9. Kitchener HC, Castle PE, Cox JT. Chapter 7: Achievements and limitations of cervical cytology screening. Vaccine. 2006;24: S3/63-70. [DOI] [PubMed]
10. Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2009;16(4):199-204. [DOI] [PubMed]
11. Agurto I, Bishop A, Sanchez G, Betancourt Z, Robles S. Perceived barriers and benefits to cervical cancer screening in Latin America. Prev Med. 2004;39(1):91-8. [DOI] [PubMed]
12. Krivak T, Mc Broom J, Elkas J. Cervical and vaginal cancer. In: Berek J, editor. Novak’s gynecology. 13th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 1199-244.
13. Zamani M, Torabian S. [Evaluation the colposcopic and histologic findings in oncology ward of Fatemieh hospital, Hamadan, Iran]. Iranian J Obstetr. 2013;16(78):1-6.
14. Almassi-Nokiani F, Akbari H. [Prevalence of invasive and pre-invasive cervical lesions in Kermanshah (2003-2007)]. J Qazvin Univ Med Sci. 2009; 13(1):42-8.
15. Mehrafza M, Amadeh-Ziabari M. [A comparative study on colposcopy and cervical biopsy findings in patients with minimally abnormal pap smear test]. J Guilan Univ Med Sci. 2003;12(46):62-8.
16. Fakor F, Aghaeenejad S, Moosavi S. [Pathologic findings of endocervical curettage in routine colposcopy in abnormal pap smear]. J Guilan Univ Med Sci. 2013;22(87):1-6.
17. Addis I, Kenneth D, Berek J. Intraepithelial disease of the cervix, vagina and vulva. In: Berek J, editor. Novak’s Gynecology. 16th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 561-85.
18. Ghaem-Maghami F, Ensani F, Behtash N, Hosseini Nejad S. [Histologic findings of uterine cervix among women with cytologic diagnosis of ASCUS (atypical squamous cells of undetermined significance)]. Tehran Univ Med J. 2004;62(4):326-31.
19. Yang RC, Mills PK, Dodge JL. Cancer screening, reproductive history, socioeconomic status, and anticipated cancer-related behavior among Hmong adults. Asian Pac J Cancer Prev. 2006;7(1):79-85. [PubMed]
20. Ehdaeevand F, Neeknejad M, Aminisani N, Chinifroush M. [Chinifroush M. Cervix dysplasia in 5000 pap smears in Ardabil]. J Ardabil Univ Med Sci. 2005;5(1):22-5.
21. Hinkula M, Pukkala E, Kyyronen P, Laukkanen P, Koskela P, Paavonen J, et al. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland. Br J Cancer. 2004;90(5):1025-9. [DOI] [PubMed]
22. Jafari M, Halimi M, Dastranj-tabrizi A, Shahamfar J. [Prevalence of for precancerous and invasive cancer lesion of cervix]. Iranian J Obstetr Gynecol Infertil. 2010;10(2):63-78.
23. Alavi S. [Prevalence of pre-malignant cervical cancer pap smears determine which factors were martyrs rehabilitation Hospital]. Tehran: Shahid Beheshti University of Medical Sciences; 2006.
24. Sasieni P, Castanon A. Call and recall cervical screening programme: Screening interval and age limits. Curr Diagn Pathol. 2006;12(2):114-26. [DOI]
25. Habibypour R, Amirkhani A, Matinnia N. [Contamination rate of trichomonas vaginalis in females referring to Taamin Ejtemayi hospitals in Hamedan in 2005]. Zahedan J Med Sci. 2006;8(4):245-51.

Add your comments about this article : Your username or Email:
Write the security code in the box

Send email to the article author


© 2015 All Rights Reserved | J Educ Community Health

Designed & Developed by : Yektaweb